In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

Traceability improves supply chain visibility, allowing pharmaceutical manufacturers to identify bottlenecks, inefficiencies, and areas of risk more effectively. Through a transparent supply chain ...

Difficulty acquiring propulsion systems and laser communications systems continue to vex satellite manufacturers.

Global supply chains run deep and have gradually honed their operational efficiency and effectiveness in the last five ...

Following are six reasons why pharmaceutical and life sciences companies must prioritize track-and-trace technology in their ...

Container-ship backlogs from New York to Houston are extending strains on troubled supply chains in the U.S. WSJ’s Paul Berger explains what’s contributing to the congestion and what impact it ...

GSK’s global supply chain is intricate, involving both primary (active pharmaceutical ingredients manufacturing ... This framework empowers GSK to precisely pinpoint bottlenecks and promptly alert ...

In short, the data will help identify potential bottlenecks and opportunities for improvements. Following are steps to successfully mapping a supply chain: Gather data. Identify which key supply ...

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

To fully realise the benefits of its inflation-curbing policies, it must put effective measures in place to remove the bottlenecks from the supply chain, making the system efficient and consumer ...